Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

JunB is crucial for maintaining healthy skin and hair follicles.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The skin and thymus develop similarly to protect and support immunity.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Alopecia areata involves immune response and gene changes affecting hair loss.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Erianin may effectively treat alopecia areata by targeting the immune system.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Skin bacteria can help wound healing by activating certain immune cells.